1. Doxorubicin, to Treat Cancers or to Cause Cardiac Injury, that is the Question

   • Masafumi Kitakaze

   Editorial Board Pages: 199 - 200

2. New Aspects on Ca2+ Antagonism During Myocardial Ischemia Surprisingly Related to Endothelial Autacoids

   • M. Schwemmer
   • E. Bassenge

   Editorial Board Pages: 201 - 204

3. Has Melatonin a Future as a Cardioprotective Agent?

   • D.J. Duncker
   • P.D. Verdouw

   Editorial Board Pages: 205 - 207

4. Antibiotic Therapy in Coronary Heart Disease—Where Do We Currently Stand?

   • Vijay Anand
   • Sandeep Gupta

   OriginalPaper Pages: 209 - 210

5. Safety of HMG-CoA Reductase Inhibitors: Focus on Atorvastatin

   • Franco Bernini
   • Andrea Poli
   • Rodolfo Paoletti

   ReviewPaper Pages: 211 - 218

6. Heat Stress Protects Against Electrophysiological Damages Induced by Acute Doxorubicin Exposure in Isolated Rat Hearts

   • Marie Joyeux
   • Diane Godin-Ribuot
   • Christophe Ribuot

   OriginalPaper Pages: 219 - 224

7. Benidipine, a Long-acting Ca Channel Blocker, Limits Infarct Size via Bradykinin- and NO-Dependent Mechanisms in Canine Hearts

   • Hiroshi Asanuma
   • Masafumi Kitakaze
   • Masatsugu Hori

   OriginalPaper Pages: 225 - 231

8. Silymarin and Vitamin E do not Attenuate and Vitamin E Might Even Enhance the Antiarrhythmic Activity of Amiodarone in a Rat Reperfusion Arrhythmia Model

   • Ildikó Gyönös
   • Márta Ágoston
   • András Vereckei

   OriginalPaper Pages: 233 - 240

9. Effects of Growth Hormone Following Chronic Angiotensin-converting Enzyme Inhibition in Chronic Heart Failure: Their Relation to Infarct Size

   • Minoru Hongo
   • Eiji Hironaka
   • Tsutomu Ryoke

   OriginalPaper Pages: 241 - 249

10. Effects of Melatonin on Ischemia and Reperfusion Injury of the Rat Heart

    • Ondrej Szárszoi
    • Girma Asemu
    • František Kolář

    OriginalPaper Pages: 251 - 257

11. In Vitro Susceptibility and Eradication of Chlamydia Pneumoniae Cardiovascular Strains from Coronary Artery Endothelium and Smooth Muscle Cells

    • Jens Gieffers
    • Werner Solbach
    • Matthias Maass

    OriginalPaper Pages: 259 - 262

12. The Elderly Hypertensive; Cardiovascular and Neurohormonal Profile

    • Peter W. de Leeuw
    • Willem H. Birkenhäger

    OriginalPaper Pages: 263 - 267

13. Antihypertensive Drugs in the Elderly—the Evidence of Benefit

    • Tony Stanton
    • John L. Reid

    OriginalPaper Pages: 269 - 273

14. How far Should we Lower Blood Pressure in the Elderly

    • Lennart Hansson

    OriginalPaper Pages: 275 - 279

15. Commentary on Treatment of Hypertension in the Elderly

    • Wilbert S. Aronow

    OriginalPaper Pages: 281 - 282